Company · CIK 1751299
Kaleido Biosciences, Inc.
| CIK | 1751299 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-05-02 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-240323 | 2020-08-04 | 2022-04-29 | 6 | |
| 333-236804 | 2020-03-02 | 2020-06-03 | 4 | |
| 333-229204 | 2019-01-11 | 2019-03-01 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-04-29 | EFFECTDeclared effective | 333-240323 | 9999999995-22-001166 |
| 2021-05-10 | EFFECTDeclared effective | 333-240323 | 9999999995-21-001857 |
| 2021-02-05 | 424B5Shelf takedown | 333-240323 | 0001193125-21-030976 |
| 2021-02-03 | 424B5Shelf takedown | 333-240323 | 0001193125-21-027483 |
| 2020-08-14 | EFFECTDeclared effective | 333-240323 | 9999999995-20-002157 |
| 2020-08-04 | S-3Shelf registered | 333-240323 | 0001193125-20-208865 |
| 2020-06-03 | 424B5Shelf takedown | 333-236804 | 0001193125-20-159057 |
| 2020-06-01 | 424B5Shelf takedown | 333-236804 | 0001193125-20-157318 |
| 2020-03-10 | EFFECTDeclared effective | 333-236804 | 9999999995-20-000538 |
| 2020-03-02 | S-3Shelf registered | 333-236804 | 0001193125-20-058089 |
| 2019-03-01 | 424B4Final prospectus | 333-229204 | 0001193125-19-061191 |
| 2019-02-27 | EFFECTDeclared effective | 333-229204 | 9999999995-19-000333 |
| 2019-02-22 | S-1/AAmendment | 333-229204 | 0001193125-19-048411 |
| 2019-02-19 | S-1/AAmendment | 333-229204 | 0001193125-19-043574 |
| 2019-01-11 | S-1Registration filed | 333-229204 | 0001193125-19-007301 |
| 2018-09-25 | DRSDraft made public | 377-02278 | 0000950123-18-009543 |